Candel Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $91k | 18k | 5.10 |
| 2025-03-31 | $81k | 14k | 5.65 |
| 2024-12-31 | $91k | 10k | 8.68 |
| 2024-09-30 | $63k | 9.1k | 6.93 |
| 2024-06-30 | $120k | 19k | 6.20 |
| 2024-03-31 | $349 | 221 | 1.58 |
| 2023-12-31 | $306 | 209 | 1.47 |
| 2023-09-30 | $191 | 203 | 0.94 |
| 2023-06-30 | $234 | 186 | 1.26 |
| 2023-03-31 | $0 | 186 | 0.00 |
| 2022-12-31 | $0 | 186 | 0.00 |
| 2022-06-30 | $4.0k | 1.2k | 3.21 |
| 2022-03-31 | $17k | 3.4k | 5.02 |
| 2021-12-31 | $20k | 2.5k | 7.91 |